U.S. health and trade authorities issued a record seven warning letters in one day to companies making CBD, the biggest federal action against the industry in over a year.
Warning letters from the U.S. Food and Drug Administration and the Federal Trade Commission this week targeted companies making corona virus-related claims.
It was the first time so many CBD companies had been targeted in a single day.
They were the first warnings issued since this year’s release of multiple scientific studies showing that CBD, cannabinoids acids and even synthetic cannabis compounds might prevent or treat COVID-19 infections.
The USDA and FTC said in a Tuesday announcement that they were alarmed to see cannabinoids companies “using research studies to claim or imply misleadingly that their CBD products will cure, mitigate, treat or prevent COVID-19.”
The CBD companies that received warnings were:
- Heaven’s Organics
- Functional Remedies dba Synchronicity Hemp Oil
- Greenway Herbal Products
- CBD Social
- UPSY LLC
- Nature’s Highway
The companies were given 48 hours apiece to scrub their websites and social media posts of product listings that “misleadingly represent them as safe and/or effective for the treatment or prevention of COVID-19.”
The warning letters were dated Monday, the same day the FDA asked Congress to change a 1994 law regulating dietary supplements “to facilitate enforcement against unlawfully marketed products.” The FDA said the changes would allow the agency “to know when new products are introduced, quickly identify dangerous or illegal products on the market, and take appropriate action to protect consumers when necessary.”